ULTRA-HIGH FIELD PROTON MR SPECTROSCOPY IN EARLY-STAGE AMYOTROPHIC LATERAL SCLEROSIS

A major hurdle in the development of effective treatments for amyotrophic lateral sclerosis (ALS) has been the lack of robust biomarkers for use as clinical trial endpoints. Neurochemical profiles obtained in vivo by high field proton magnetic resonance spectroscopy ((1)H-MRS) can potentially provid...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurochem Res
Asıl Yazarlar: Cheong, Ian, Marjańska, Małgorzata, Deelchand, Dinesh K., Eberly, Lynn E., Walk, David, Öz, Gülin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5488866/
https://ncbi.nlm.nih.gov/pubmed/28367604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11064-017-2248-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller